CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operating Officer sold 483 shares at $2.45 ($1,184)
- 4 Open-market sale Pres. & Chief Executive Offic sold 1,972 shares at $2.89 ($5,699)
- 4 Open-market sale Chief Operating Officer sold 714 shares at $2.89 ($2,063)
- 4 Open-market sale S.V.P., General Counsel sold 1,185 shares at $2.89 ($3,425)
- 4 Open-market sale VP, Finance sold 476 shares at $2.91 ($1,385)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale BRISTOW MICHAEL R sold 724 shares at $3.52 ($2,548)
- 4 Open-market sale S.V.P., General Counsel sold 366 shares at $3.52 ($1,288)
Page 10 of 23 · 459 filings